Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eyelid Neoplasms | 2 | 2020 | 29 | 0.930 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2020 | 24 | 0.660 |
Why?
|
| Orbital Neoplasms | 4 | 2023 | 49 | 0.420 |
Why?
|
| Orbital Diseases | 4 | 2021 | 66 | 0.350 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2008 | 40 | 0.270 |
Why?
|
| Hamartoma | 2 | 2007 | 51 | 0.270 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2007 | 13 | 0.260 |
Why?
|
| Cartilage | 1 | 2007 | 52 | 0.260 |
Why?
|
| Chondrocytes | 1 | 2007 | 49 | 0.260 |
Why?
|
| Mesoderm | 1 | 2007 | 106 | 0.250 |
Why?
|
| Optic Nerve Diseases | 2 | 2023 | 80 | 0.230 |
Why?
|
| Calcinosis | 1 | 2007 | 182 | 0.230 |
Why?
|
| Cornea | 5 | 2018 | 561 | 0.220 |
Why?
|
| Orbital Implants | 2 | 2021 | 11 | 0.220 |
Why?
|
| Fasciitis | 1 | 2024 | 18 | 0.210 |
Why?
|
| Lacrimal Duct Obstruction | 1 | 2024 | 20 | 0.210 |
Why?
|
| Nasolacrimal Duct | 1 | 2024 | 24 | 0.210 |
Why?
|
| Canaliculitis | 1 | 2023 | 3 | 0.210 |
Why?
|
| Eye Infections, Fungal | 3 | 2018 | 68 | 0.200 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2023 | 59 | 0.200 |
Why?
|
| Candidiasis | 3 | 2018 | 131 | 0.200 |
Why?
|
| Cysts | 1 | 2023 | 89 | 0.190 |
Why?
|
| Dermoid Cyst | 1 | 2023 | 36 | 0.190 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2023 | 163 | 0.180 |
Why?
|
| Keratitis | 2 | 2018 | 104 | 0.160 |
Why?
|
| Ophthalmologic Surgical Procedures | 2 | 2018 | 95 | 0.160 |
Why?
|
| Orbital Fractures | 1 | 2021 | 38 | 0.160 |
Why?
|
| Choroid Neoplasms | 1 | 1999 | 9 | 0.150 |
Why?
|
| Nevus, Pigmented | 1 | 1999 | 30 | 0.150 |
Why?
|
| Systemic Vasculitis | 1 | 2018 | 2 | 0.140 |
Why?
|
| Hemangioblastoma | 1 | 2018 | 9 | 0.140 |
Why?
|
| Candida parapsilosis | 1 | 2018 | 3 | 0.140 |
Why?
|
| Exophthalmos | 1 | 2018 | 31 | 0.130 |
Why?
|
| Stomach Neoplasms | 1 | 2023 | 579 | 0.130 |
Why?
|
| Melanoma | 2 | 2009 | 920 | 0.130 |
Why?
|
| Retinal Neoplasms | 1 | 2018 | 73 | 0.130 |
Why?
|
| Diagnosis, Differential | 4 | 2023 | 1897 | 0.130 |
Why?
|
| Orbit | 1 | 2018 | 81 | 0.130 |
Why?
|
| Neoplasms, Second Primary | 1 | 1999 | 141 | 0.130 |
Why?
|
| Neuroendocrine Tumors | 1 | 2018 | 71 | 0.130 |
Why?
|
| Sclera | 2 | 2009 | 45 | 0.120 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 284 | 0.110 |
Why?
|
| Conjunctival Neoplasms | 1 | 2013 | 13 | 0.100 |
Why?
|
| Eye Neoplasms | 1 | 2013 | 38 | 0.100 |
Why?
|
| Retinal Detachment | 1 | 2013 | 42 | 0.100 |
Why?
|
| Uveal Neoplasms | 2 | 2013 | 31 | 0.100 |
Why?
|
| Humans | 26 | 2024 | 130857 | 0.100 |
Why?
|
| Laryngeal Neoplasms | 1 | 2013 | 85 | 0.100 |
Why?
|
| Orbital Myositis | 1 | 2012 | 4 | 0.090 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2012 | 7 | 0.090 |
Why?
|
| Silicon Dioxide | 1 | 2012 | 30 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2023 | 2104 | 0.090 |
Why?
|
| Visual Acuity | 5 | 2018 | 527 | 0.090 |
Why?
|
| Female | 21 | 2024 | 70681 | 0.080 |
Why?
|
| Ileal Neoplasms | 1 | 1990 | 5 | 0.080 |
Why?
|
| Eye Enucleation | 4 | 2013 | 34 | 0.080 |
Why?
|
| Carcinoid Tumor | 1 | 1990 | 24 | 0.080 |
Why?
|
| Endothelium, Corneal | 2 | 1989 | 27 | 0.080 |
Why?
|
| Eyelid Diseases | 2 | 2023 | 60 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 875 | 0.080 |
Why?
|
| Gold Radioisotopes | 1 | 2009 | 2 | 0.070 |
Why?
|
| Candida albicans | 2 | 2000 | 87 | 0.070 |
Why?
|
| Descemet Membrane | 1 | 1989 | 10 | 0.070 |
Why?
|
| Aged | 8 | 2023 | 20972 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 756 | 0.070 |
Why?
|
| Brachytherapy | 1 | 2009 | 86 | 0.070 |
Why?
|
| Radiation Injuries | 1 | 2009 | 145 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2023 | 3877 | 0.070 |
Why?
|
| Strabismus | 1 | 2007 | 65 | 0.060 |
Why?
|
| Blepharoptosis | 1 | 2007 | 67 | 0.060 |
Why?
|
| Triamcinolone | 2 | 2012 | 12 | 0.060 |
Why?
|
| Glucocorticoids | 3 | 2012 | 341 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 1990 | 453 | 0.060 |
Why?
|
| Eyelids | 2 | 2023 | 107 | 0.050 |
Why?
|
| Erdheim-Chester Disease | 1 | 2004 | 28 | 0.050 |
Why?
|
| Male | 15 | 2024 | 64722 | 0.050 |
Why?
|
| Fusobacterium Infections | 1 | 2004 | 9 | 0.050 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2004 | 7 | 0.050 |
Why?
|
| Thrombophlebitis | 1 | 2004 | 19 | 0.050 |
Why?
|
| Fusobacterium nucleatum | 1 | 2004 | 19 | 0.050 |
Why?
|
| Dacryocystorhinostomy | 1 | 2024 | 22 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 674 | 0.050 |
Why?
|
| Dyspnea | 1 | 2004 | 160 | 0.050 |
Why?
|
| Blindness | 1 | 2004 | 71 | 0.050 |
Why?
|
| Durapatite | 1 | 2003 | 11 | 0.050 |
Why?
|
| Eye Infections, Bacterial | 1 | 2004 | 82 | 0.050 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2003 | 31 | 0.050 |
Why?
|
| Eye Diseases | 1 | 2004 | 108 | 0.050 |
Why?
|
| Twins, Monozygotic | 1 | 2023 | 124 | 0.050 |
Why?
|
| Middle Aged | 11 | 2018 | 28513 | 0.050 |
Why?
|
| Nose | 1 | 2023 | 112 | 0.050 |
Why?
|
| Pericardium | 1 | 2003 | 104 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2023 | 295 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 1989 | 895 | 0.040 |
Why?
|
| Fundus Oculi | 2 | 2018 | 35 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 1608 | 0.040 |
Why?
|
| Fluorescein Angiography | 2 | 2018 | 64 | 0.040 |
Why?
|
| Corneal Ulcer | 1 | 2000 | 56 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2021 | 144 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2023 | 1232 | 0.040 |
Why?
|
| Contact Lenses | 1 | 1999 | 40 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning Transmission | 1 | 1999 | 5 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 1990 | 1395 | 0.040 |
Why?
|
| Melanocytes | 1 | 1999 | 45 | 0.040 |
Why?
|
| Keloid | 1 | 1998 | 11 | 0.040 |
Why?
|
| Mycophenolic Acid | 1 | 2018 | 61 | 0.030 |
Why?
|
| Pyridones | 1 | 1998 | 149 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2021 | 498 | 0.030 |
Why?
|
| Immunosuppressive Agents | 2 | 2018 | 658 | 0.030 |
Why?
|
| Laser Coagulation | 1 | 2018 | 117 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 300 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 6785 | 0.030 |
Why?
|
| Conjunctival Diseases | 1 | 1996 | 31 | 0.030 |
Why?
|
| Vasculitis | 1 | 1996 | 46 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2018 | 296 | 0.030 |
Why?
|
| Infant | 3 | 2007 | 13330 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 1152 | 0.030 |
Why?
|
| Skin Diseases | 1 | 1996 | 141 | 0.030 |
Why?
|
| Scleral Diseases | 1 | 2013 | 1 | 0.030 |
Why?
|
| Muscle Neoplasms | 1 | 2013 | 21 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 449 | 0.030 |
Why?
|
| Injections, Intraocular | 1 | 2012 | 7 | 0.020 |
Why?
|
| Eye Pain | 1 | 2012 | 11 | 0.020 |
Why?
|
| Diplopia | 1 | 2012 | 43 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 632 | 0.020 |
Why?
|
| Oculomotor Muscles | 1 | 2012 | 80 | 0.020 |
Why?
|
| Adult | 7 | 2009 | 31275 | 0.020 |
Why?
|
| Chromogranin A | 1 | 1990 | 4 | 0.020 |
Why?
|
| Synaptophysin | 1 | 1990 | 18 | 0.020 |
Why?
|
| Chromogranins | 1 | 1990 | 30 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1990 | 234 | 0.020 |
Why?
|
| Aneuploidy | 1 | 1990 | 137 | 0.020 |
Why?
|
| Pigment Epithelium of Eye | 1 | 1989 | 37 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1990 | 284 | 0.020 |
Why?
|
| Serotonin | 1 | 1990 | 211 | 0.020 |
Why?
|
| Rabbits | 2 | 2000 | 573 | 0.020 |
Why?
|
| Ethoxzolamide | 1 | 1988 | 1 | 0.020 |
Why?
|
| Aqueous Humor | 1 | 1988 | 17 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 1999 | 4669 | 0.020 |
Why?
|
| Necrosis | 1 | 2009 | 194 | 0.020 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 1988 | 27 | 0.020 |
Why?
|
| Child | 4 | 2023 | 26223 | 0.020 |
Why?
|
| Thiazoles | 1 | 1988 | 110 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1990 | 771 | 0.020 |
Why?
|
| Retinal Diseases | 1 | 1989 | 151 | 0.020 |
Why?
|
| Conjunctiva | 2 | 1999 | 197 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 10025 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 12915 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1990 | 1607 | 0.010 |
Why?
|
| Cattle | 1 | 2003 | 501 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2009 | 17684 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 1165 | 0.010 |
Why?
|
| Prognosis | 1 | 1990 | 4936 | 0.010 |
Why?
|
| Triamcinolone Acetonide | 1 | 1999 | 20 | 0.010 |
Why?
|
| Virulence | 1 | 2000 | 270 | 0.010 |
Why?
|
| Electrophoresis, Cellulose Acetate | 1 | 1998 | 3 | 0.010 |
Why?
|
| Animals | 4 | 2003 | 33937 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 1998 | 36 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 1998 | 42 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 6242 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1998 | 708 | 0.010 |
Why?
|
| Child, Preschool | 3 | 2003 | 15016 | 0.010 |
Why?
|
| Prednisone | 1 | 1996 | 241 | 0.010 |
Why?
|
| Body Weight | 1 | 1998 | 989 | 0.010 |
Why?
|
| Risk Factors | 1 | 2009 | 11004 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1996 | 436 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1996 | 302 | 0.010 |
Why?
|
| Skull | 1 | 1994 | 153 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 2553 | 0.010 |
Why?
|
| Benzothiazoles | 1 | 1988 | 31 | 0.000 |
Why?
|
| Conjunctivitis | 1 | 1988 | 21 | 0.000 |
Why?
|
| Permeability | 1 | 1988 | 119 | 0.000 |
Why?
|
| Reference Values | 1 | 1988 | 680 | 0.000 |
Why?
|
| Circadian Rhythm | 1 | 1988 | 315 | 0.000 |
Why?
|
| Adolescent | 1 | 2003 | 20839 | 0.000 |
Why?
|
| Mice | 1 | 1998 | 18245 | 0.000 |
Why?
|